In early October, Providence Cancer Institute of Oregon and AIM at Melanoma Foundation held a virtual patient education event for people with melanoma, plus their family and friends.
"Basics of Clinical Trials,” presented by Chris Fountain, RN, Clinician-Research, Providence Cancer Institute (video)
“Case Studies Illustrating Recent Advances in Medical Care,” presented by Brendan D. Curti, M.D., Medical Oncologist, Medical Director, Providence Melanoma Program, Providence Cancer Institute (video)
“New Treatments Under Development in Melanoma,” presented by Matthew H. Taylor, M.D., Medical Oncologist, Co-Medical Director, Providence Melanoma Program, Providence Cancer Institute (video)
“Communication with Family & Friends,” presented by Dawn Brucker, LCSW, OSW-C, Oncology Social Worker, Providence Cancer Institute (video)
We host a variety of classes, educational talks, and other events throughout the year. Learn more at providence.org.
Multi-indication clinical trials help evaluate new medications for future treatments
Studies will evaluate combination therapies for two types of melanoma
Melanoma studies: can adjuvant immunotherapy improve recurrence-free survival?